How should I evaluate and manage a 21-year-old man with a three-month history of a rough hyperkeratotic plantar lesion with black dots and recent weight‑bearing pain, consistent with a verruca plantaris?

Management of Plantar Verruca (Verruca Plantaris)

For this 21-year-old male with a 3-month plantar lesion showing characteristic black dots and recent weight-bearing pain, begin with sharp debridement followed by topical salicylic acid therapy, with cryotherapy reserved for resistant cases.

Initial Diagnostic Confirmation

The clinical presentation is classic for verruca plantaris:

• Black dots (thrombosed capillaries) are pathognomonic
• Hyperkeratotic surface with rough texture
• Weight-bearing pain (recent onset suggests deeper extension)
• Duration of 3 months indicates established infection

Critical Differential to Exclude

Before proceeding with treatment, rule out verrucous carcinoma if the lesion shows any atypical features 1. While rare, plantar verrucous carcinoma can masquerade as a recalcitrant wart for years. Consider biopsy if:

• Lesion fails to respond to standard therapy after 3-4 months
• Progressive enlargement despite treatment
• Ulceration or malodorous discharge develops
• Patient is elderly (though less likely at age 21)

First-Line Treatment Algorithm

Step 1: Sharp Debridement

• Perform scalpel debridement to remove hyperkeratotic tissue 2
• This exposes the underlying wart tissue and enhances penetration of topical agents
• Repeat every 1-2 weeks during treatment 3

Step 2: Topical Therapy (Choose One)

Option A: Salicylic Acid + 5-Fluorouracil (Preferred for faster resolution)

• Apply 0.5% or 5% fluorouracil combined with 17-40% salicylic acid twice daily 3
• Evidence shows 100% clearance rate in 20 patients with mean resolution time of 82.5 days 3
• The British Association of Dermatologists guidelines support this combination, showing 63% clearance vs. 11% with SA alone 2
• Monitor for local dermatitis (10% incidence); treat with temporary discontinuation and topical corticosteroid if needed 3

Option B: Salicylic Acid Monotherapy (If 5-FU unavailable)

• Apply 17-40% salicylic acid daily under occlusion
• Less effective than combination therapy but widely available 2

Step 3: Adjunctive Measures

• Pressure redistribution: Recommend cushioned insoles or donut pads to offload the affected area during healing
• Proper footwear: Supportive shoes to minimize friction and pressure
• Avoid barefoot walking in communal areas to prevent spread 4

Second-Line Treatment (If No Response After 8-12 Weeks)

Cryotherapy

• Double freeze-thaw cycle with liquid nitrogen 2
• Evidence shows 75% complete response rate at 3 months 5
• More effective for thicker lesions (69% vs. 52% for photodynamic therapy) 5
• Caution: May cause scarring and hypopigmentation; counsel patient accordingly

Alternative: Cantharidin Cream

• Recent evidence shows 86% cure rate at 12 weeks 6
• May be better tolerated than cryotherapy
• Apply topically; causes blister formation that lifts the wart

Treatment Monitoring

Follow-up schedule:

• Week 2: Assess for dermatitis, perform repeat debridement
• Week 4: Evaluate response; if no improvement, consider adding cryotherapy
• Week 12: If persistent, reassess diagnosis and consider biopsy to exclude verrucous carcinoma 1

Expected timeline:

• Most cases resolve within 3 months with combination therapy 3
• 15% recurrence rate even after successful treatment 3

Critical Pitfalls to Avoid

1. Do not assume all hyperkeratotic plantar lesions are warts: The presence of black dots is highly specific, but atypical features warrant biopsy 7, 8, 1

2. Do not over-debride: Aggressive debridement can worsen pain and delay healing 9

3. Do not use surgical excision as first-line: Surgery has no proven advantage and risks scarring in weight-bearing areas 2. Reserve for diagnostic uncertainty only.

4. Do not continue ineffective treatment beyond 12 weeks: Persistent lesions despite appropriate therapy require histologic evaluation 1

5. Address pain immediately: The recent onset of weight-bearing pain (5 days) suggests the lesion is impacting quality of life. Offloading with padding provides immediate symptomatic relief while definitive treatment takes effect.

Special Considerations for This Patient

At age 21, this patient likely has normal immune function, predicting good treatment response. However:

• HPV transmission risk: Counsel on avoiding barefoot contact in shared spaces 4
• Recurrence prevention: Continue monitoring for 6 months post-resolution, as 15% will recur 3
• Compliance: Twice-daily application requires commitment; ensure patient understands the 2-3 month treatment duration